Robin C. Kramer
Executive Vice President and Chief Financial OfficeratBiogen· In the 2025 proxy
Pay in FY2025Biogen stock +15.1% the same year
Robin C. Kramer was paid $5.8M in FY2025 (Dec). Biogen stock rose 15.1% that year.
Pay$100 in the stock at the end of FY24 → $115
Experience
- BiogenPublic company · 1 yr
- Executive Vice President and Chief Financial Officer2025 – Present · 1 yrStock in role +64%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?